Spinal cord ischaemia complicating meningococcal meningitis.
Spinal cord dysfunction complicating meningococcal meningitis.
Spinal cord dysfunction in neonatal meningococcal meningitis.
Meningococcal Meningitis(Archived).
Yadav S, Rammohan G.
2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Spinal cord infarction and tetraplegia--rare complications of meningococcal meningitis.
O'Farrell R, Thornton J, Brennan P, Brett F, Cunningham AJ.
Br J Anaesth. 2000 Apr;84(4):514-7. doi: 10.1093/oxfordjournals.bja.a013482.
Spinal cord infarction as a severe complication of meningococcal meningitis.
Van Egeraat SC, Van Munster ET, Bodewes HW, Van Der Hoeven JG.
Eur J Intern Med. 2003 Oct;14(6):383-385. doi: 10.1016/s0953-6205(03)90007-0.
Spinal cord dysfunction complicating meningococcal meningitis.
Khan J, Altafullah I, Ishaq M.
Postgrad Med J. 1990 Apr;66(774):302-3. doi: 10.1136/pgmj.66.774.302.
Spinal cord ischaemia complicating meningococcal meningitis.
Swart SS, Pye IF.
Postgrad Med J. 1980 Sep;56(659):661-2. doi: 10.1136/pgmj.56.659.661.
Spinal cord dysfunction in neonatal meningococcal meningitis.
Kirkpatrick M, Brooker RJ, Helms PJ, Cole GF.
Eur J Pediatr. 1994 May;153(5):367-8. doi: 10.1007/BF01956421.
Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis.
Kastenbauer S, Winkler F, Fesl G, Schiel X, Ostermann H, Yousry TA, Pfister HW.
Arch Neurol. 2001 May;58(5):806-10. doi: 10.1001/archneur.58.5.806.
A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH, Haseeb MA, Idris AA, Lapeyssonnie L, Sanborn WR, Sippel JE.
Bull World Health Organ. 1973;49(3):301-5.
Fluctuations in serogroup B meningococcal vaccine antigens prior to routine MenB vaccination in France.
Falguières M, Hong E, Denizon M, Terrade A, Taha MK, Deghmane AE.
Commun Med (Lond). 2025 Mar 25;5(1):87. doi: 10.1038/s43856-025-00800-2.
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness.
Borrow R, Martinón-Torres F, Abitbol V, Andani A, Preiss S, Muzzi A, Serino L, Sohn WY.
Expert Rev Vaccines. 2023 Jan-Dec;22(1):738-748. doi: 10.1080/14760584.2023.2244596.
